Remarkably, a higher frequency of IDH1/IDH2 (20%) was detected in adult AML via the WGS and WES approach (Cancer Genome Atlas Research, 2013), suggesting NGS could be a more sensitive approach in detecting subclonal mutations in heterogenous AML blast cells. Here, IDH2 is linked to acute myeloid leukemia.